Vertebrobasilar insufficiency

Current Treatment Options in Cardiovascular Medicine

Volumn 8, Issue 2, 2006, Pages 111-119

  Doss, Arockia ^a   Phatouros, Constantine C ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALTEPLASE; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLARITHROMYCIN; CLOPIDOGREL; CYCLOSPORIN; DEXTRAN; DIGOXIN; DIPYRIDAMOLE; ERYTHROMYCIN; GEMFIBROZIL; HEPARIN; HYDROXYCHLOROQUINE; INDAPAMIDE; KETOCONAZOLE; LOW MOLECULAR WEIGHT HEPARIN; NICOTINE; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; RECOMBINANT PLASMINOGEN ACTIVATOR; TETRACYCLINE; TICLOPIDINE; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ALOPECIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTICOAGULATION; ARTHRALGIA; ATHEROSCLEROSIS; BLEEDING; BLEEDING DISORDER; BLOOD DISEASE; BRAIN HEMORRHAGE; BRAIN PERFUSION; BRAIN STEM; BRONCHOSPASM; BYPASS SURGERY; CEREBELLUM; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; CONFUSION; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG COST; DRUG HYPERSENSITIVITY; DUODENUM ULCER; DYSPEPSIA; ENDOVASCULAR SURGERY; EOSINOPHILIA; ERYTHEMA MULTIFORME; FEVER; FLATULENCE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HALLUCINATION; HEADACHE; HEPATITIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPOTENSION; LEUKOPENIA; LIFESTYLE; NAUSEA; NEUTROPENIA; OCCIPITAL CORTEX; OSTEOPOROSIS; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRURITUS; PURPURA; RASH; REVASCULARIZATION; REVIEW; RISK FACTOR; RISK REDUCTION; SKIN NECROSIS; STENT; STOMACH ULCER; SYMPTOM; TASTE DISORDER; THROMBOCYTOPENIA; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; URTICARIA; VASCULITIS; VERTEBROBASILAR INSUFFICIENCY; VERTIGO; VOMITING;

EID: 33645576935     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-006-0003-0     Document Type: Review

References (28)

1. Bamford J, Sandercock P, Dennis M, et al.: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
2. Bogousslavsky J, van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988, 19:1083-1092.
3. Lang E, Afilalo M: Vertebrobasilar atherothrombotic disease. eMedicine [serial online]. http://www.emedicine.com/emerg/topic834.htm. July 2, 2004.
4. British National Formulary: rtPA, Heparin, Clopidogrel, Ticlopidine, Dipyridamole, Atorvastatin, ACE inhibitors and Abciximab. http://www.bnf.org/bnf/bnf/current/openat/index.htm.
5. Wardlaw JM, del Zoppo G, Yamaguchi T: Thrombolysis for acute ischaemic stroke (Cochrane Review). In The Cochrane Library, Issue 3 (update software). Oxford: 2001.
6. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.: Comparison of warfarin and aspirin symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305-1316.
7. Koroshetz WJ: Warfarin, aspirin and intracranial vascular disease. N Engl J Med 352:1368-1370.
8. Chen ZM, Sandercock P, Pan HC, et al.: Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 2000, 31:1240-1249.
9. Jones L, Griffin S, Palmer S, et al.: Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technol Assess 2004, 8(38). http://www.ncchta.org/execsumm/summ838.htm.
10. Diener HC, Bougousslavsky J, Brass LM, et al.: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trail. Lancet 2004, 364:331-337.
11. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee [no authors listed]. Lancet 1996, 348:1329-1339.
12. Diener HC: Secondary prevention of stroke with antiplatelet drugs. Med Klin (Munich) 2004, 99(suppl 1):21-25.
13. Colhoun HM, Betteridge DJ, Durrington PN: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004, 364:685-696.
14. Chalmers J, MacMahon S: Perindopril Protection Against Recurrent Stroke Study (PROGRESS): interpretation and implementation. J Hypertens Suppl 2003, 21(suppl 5):S9-S14.
15. Hass WK, Fields WS, North RR, et al.: Joint study of extracranial arterial occlusion. II. Arteriography techniques, sites, and complications. JAMA 1968, 203:961-968.
16. Chastain HD, Campbell MS, Iyer S, et al.: Extracranial vertebral artery stent placement: in-hospital and follow-up results. J Neurosurg 1999, 91:547-552.
17. Jenkins JS, White CJ, Ramee SR, et al.: Vertebral artery stenting. Catheter Cardiovasc Interv 2001, 54:1-5.
18. Malek AM, Higashida RT, Phatouros CC, et al.: Treatment of posterior circulation ischaemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999, 30:2073-2085.
19. Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000, 55:490-497.
20. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA) Study results. The SSYLVIA Study Investigators [no authors listed]. Stroke 2004, 35:1388-1392.
21. Qureshi AI: Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 2004, 363:804-813.
22. Cloud GC, Crawley F, Clifton A, et al.: Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series. J Neurol Neurosurg Psychiatry 2003, 74:586-590.
23. Albuquerque FC, Fiorella D, Han P, et al.: A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery 2003, 53:607-614.
24. Qureshi AI, Ringer AJ, Suri MF, et al.: Acute interventions for ischaemic stroke: present status and future directions. J Endovasc Ther 2000, 7:423-428.
25. Phatouros CC, Higashida RT, Malek AM, et al.: Endovascular treatment of noncarotid extracranial cerebrovascular disease. Neurosurg Clin N Am 2000, 11:331-350.
26. Mahon BR, Nesbit GM, Barnwell SL, et al.: North American Clinical Experience with the EKOS MicroLysUS infusion catheter for treatment of embolic stroke. Am J Neuroradiol 2003, 24:534-538.
27. Lutsep HL, Campbell M, Clark WM: EPAR therapy system for treatment of acute stroke: safety study results. Stroke 2001, 32:319b.
28. Levy EI, Hanel RA, Howington JU, et al.: Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and response. J Neurosurg 2004, 100:688-694.